top of page
it's where dermatology lives
Studies examine optimal topical, systemic Txs for AD
Two reviews from researchers at McMaster University in Hamilton have identified the most effective topical and systemic treatments for...
Allan Ryan
Sep 18, 20232 min read
New oral JAK inhibitor effective for moderate-to-severe AD
Recently published findings from clinical trials of the oral Janus kinase (JAK) inhibitor upadacitinib show it is highly effective in...
John Evans
May 21, 20212 min read
Featured Posts
bottom of page